Study,Year,PMID,experimental_events,experimental_total,control_events,control_total,Intervention,Intervention,Male,GI_cancers,GU,ECOG_0
HOKUSAI-VTE,2017,29231094,41,522,59,524,Edoxaban,Other,0.595,0.21,0.13,0.31
SELECT-D,2018,9746227,8,203,18,203,Rivaroxaban,Other,0.525,0.1,0.11,0.31
ADAM VTE,2019,31630479,1,145,9,142,Apixaban,Apixaban,0.56,0.17,0.09,0.24
CARAVAGGIO,2020,32223112,32,576,46,579,Apixaban,Apixaban,0.492,0.25,0.12,0.3
,,,,,,,,,,,,
,Cancer rates need checking,,,,,,,,,,,
